Clinical Trial: A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Mezigdomide in Healthy Participants and Those With Mild, Moderate, and Severe Hepatic Impairment
Brief Summary:
The aim of this study is to measure the concentration levels of mezigdomide in the blood of participants with mild, moderate, and severe hepatic impairment, and in matched healthy control participants with normal hepatic function.
Read more